Literature DB >> 27712099

The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis.

Lonnele J Ball1, Oxana Palesh1, Lance J Kriegsfeld1.   

Abstract

Most physiological processes in the brain and body exhibit daily (circadian) rhythms coordinated by an endogenous master clock located in the suprachiasmatic nucleus of the hypothalamus that are essential for normal health and functioning. Exposure to sunlight during the day and darkness at night optimally entrains biological rhythms to promote homeostasis and human health. Unfortunately, a major consequence of the modern lifestyle is increased exposure to sun-free environments during the day and artificial lighting at night. Additionally, behavioral disruptions to circadian rhythms (ie, repeated transmeridian flights, night or rotating shift work, or sleep disturbances) have a profound influence on health and have been linked to a number of pathological conditions, including endocrine-dependent cancers. Specifically, night shift work has been identified as a significant risk factor for breast cancer in industrialized countries. Several mechanisms have been proposed by which shift work-induced circadian disruptions promote cancer. In this review, we examine the importance of the brain-body link through which circadian disruptions contribute to endocrine-dependent diseases, including breast carcinogenesis, by negatively impacting neuroendocrine and neuroimmune cells, and we consider preventive measures directed at maximizing circadian health.

Entities:  

Mesh:

Year:  2016        PMID: 27712099      PMCID: PMC5045494          DOI: 10.1210/er.2015-1133

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  206 in total

1.  Changing incidence of breast cancer in Japanese-American women.

Authors:  P Buell
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

2.  Nighttime light level co-distributes with breast cancer incidence worldwide.

Authors:  Itai Kloog; Richard G Stevens; Abraham Haim; Boris A Portnov
Journal:  Cancer Causes Control       Date:  2010-08-03       Impact factor: 2.506

3.  Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones.

Authors:  H Besedovsky; A del Rey; E Sorkin; C A Dinarello
Journal:  Science       Date:  1986-08-08       Impact factor: 47.728

4.  Circadian transcription profile of mouse breast cancer under light-dark and dark-dark conditions.

Authors:  Eun-Young Oh; Xiaoming Yang; Alex Friedman; Christine M Ansell; Jovelyn Du-Quiton; Dinah F Quiton; Patricia A Wood; William J M Hrushesky
Journal:  Cancer Genomics Proteomics       Date:  2010 Nov-Dec       Impact factor: 4.069

5.  Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors.

Authors:  Ann M Berger; Melody Hertzog; Carol R Geary; Patricia Fischer; Lynne Farr
Journal:  J Cancer Surviv       Date:  2012-04-07       Impact factor: 4.442

6.  Dysregulation of inflammatory responses by chronic circadian disruption.

Authors:  Oscar Castanon-Cervantes; Mingwei Wu; J Christopher Ehlen; Ketema Paul; Karen L Gamble; Russell L Johnson; Rachel C Besing; Michael Menaker; Andrew T Gewirtz; Alec J Davidson
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

7.  Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions.

Authors:  F K Stephan; I Zucker
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

Review 8.  Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis.

Authors:  Nina Buscemi; Ben Vandermeer; Nicola Hooton; Rena Pandya; Lisa Tjosvold; Lisa Hartling; Sunita Vohra; Terry P Klassen; Glen Baker
Journal:  BMJ       Date:  2006-02-10

9.  The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial.

Authors:  Melissa Voigt Hansen; Michael Tvilling Madsen; Ida Hageman; Lars Simon Rasmussen; Susanne Bokmand; Jacob Rosenberg; Ismail Gögenur
Journal:  BMJ Open       Date:  2012-01-11       Impact factor: 2.692

10.  Induction of the CLOCK gene by E2-ERα signaling promotes the proliferation of breast cancer cells.

Authors:  Liyun Xiao; Alan K Chang; Ming-Xi Zang; Hailian Bi; Shujing Li; Miao Wang; Xinrong Xing; Huijian Wu
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

View more
  13 in total

1.  Shift Work and Sleep: Medical Implications and Management.

Authors:  Shazia Jehan; Ferdinand Zizi; Seithikurippu R Pandi-Perumal; Alyson K Myers; Evan Auguste; Girardin Jean-Louis; Samy I McFarlane
Journal:  Sleep Med Disord       Date:  2017-10-06

2.  A novel approach to management of sleep-associated problems in patients with breast cancer (MOSAIC) during chemotherapy : A pilot study.

Authors:  Oxana Palesh; Natalie Solomon; Elisa Hofmeister; Booil Jo; Hanyang Shen; Erin Cassidy-Eagle; Pasquale F Innominato; Karen Mustian; Shelli Kesler
Journal:  Sleep       Date:  2020-10-13       Impact factor: 5.849

3.  Chronic insomnia in the setting of MTHFR polymorphism.

Authors:  Vidhi Kapoor; Nathaniel F Watson; Lonnele Ball
Journal:  J Clin Sleep Med       Date:  2022-04-01       Impact factor: 4.062

Review 4.  Melatonin and urological cancers: a new therapeutic approach.

Authors:  Mohammad Hossein Mehrzadi; Azam Hosseinzadeh; Kobra Bahrampour Juybari; Saeed Mehrzadi
Journal:  Cancer Cell Int       Date:  2020-09-10       Impact factor: 5.722

Review 5.  The Effect of Light Exposure at Night (LAN) on Carcinogenesis via Decreased Nocturnal Melatonin Synthesis.

Authors:  Aldo Giudice; Anna Crispo; Maria Grimaldi; Andrea Polo; Sabrina Bimonte; Mario Capunzo; Alfonso Amore; Giovanni D'Arena; Pellegrino Cerino; Alfredo Budillon; Gerardo Botti; Susan Costantini; Maurizio Montella
Journal:  Molecules       Date:  2018-05-29       Impact factor: 4.411

Review 6.  Extracellular Vesicles: Potential Participants in Circadian Rhythm Synchronization.

Authors:  Shi-Cong Tao; Shang-Chun Guo
Journal:  Int J Biol Sci       Date:  2018-09-07       Impact factor: 6.580

7.  G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment.

Authors:  Yool Lee; Nicholas F Lahens; Shirley Zhang; Joseph Bedont; Jeffrey M Field; Amita Sehgal
Journal:  PLoS Biol       Date:  2019-04-30       Impact factor: 8.029

8.  Women with hereditary breast cancer predispositions should avoid using their smartphones, tablets, and laptops at night.

Authors:  Seyed Ali Reza Mortazavi; Seyed Mohammad Javad Mortazavi
Journal:  Iran J Basic Med Sci       Date:  2018-02       Impact factor: 2.699

9.  Feasibility and acceptability of brief behavioral therapy for cancer-related insomnia: effects on insomnia and circadian rhythm during chemotherapy: a phase II randomised multicentre controlled trial.

Authors:  Oxana Palesh; Caroline Scheiber; Shelli Kesler; Michelle C Janelsins; Joseph J Guido; Charles Heckler; Mallory G Cases; Jessica Miller; Nick G Chrysson; Karen M Mustian
Journal:  Br J Cancer       Date:  2018-07-20       Impact factor: 7.640

10.  Long-term exposure to road traffic noise and incidence of breast cancer: a cohort study.

Authors:  Zorana Jovanovic Andersen; Jeanette Therming Jørgensen; Lea Elsborg; Søren Nymand Lophaven; Claus Backalarz; Jens Elgaard Laursen; Torben Holm Pedersen; Mette Kildevæld Simonsen; Elvira Vaclavik Bräuner; Elsebeth Lynge
Journal:  Breast Cancer Res       Date:  2018-10-05       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.